Search papers, labs, and topics across Lattice.
This narrative review examines the role of digital medicine and remote patient monitoring (RPM) in heart failure (HF) management, focusing on strategies for early detection, proactive intervention, and personalized care. The review synthesizes evidence from RCTs, registries, and emerging digital health technologies, highlighting the potential of integrated digital interventions to reduce HF hospitalizations, improve quality of life, and optimize resource utilization. The authors emphasize that clinical benefit depends on prompt clinical response and multidisciplinary cooperation, not solely on technology.
Digital medicine, when combined with prompt clinical response and multidisciplinary cooperation, can significantly improve outcomes in heart failure management by enabling early detection and proactive intervention.
BACKGROUND Heart failure (HF) is a progressive, multisystem syndrome characterized by recurrent decompensation, high hospitalization rates, and substantial mortality. Conventional HF management is mainly episodic and often fails to detect worsening conditions in advanced disease. Digital medicine and remote patient monitoring (RPM) hold promise for advancing HF care by enabling earlier detection, proactive action, and personalized care. METHODS We conduct a narrative review to summarize evidence from randomized clinical trials, real-world registries, and emerging digital health technologies regarding the present and future utility of digital medicine in HF care. There is greater emphasis on pathophysiology-based surveillance, personalized care models, and integration into planned health care pathways. RESULTS Integrated digital interventions, such as implantable hemodynamic monitoring, organized telemedicine programs, or device-based diagnostic technologies, can minimize HF hospitalizations, prolong life, improve quality of life, and optimize resource utilization in health care systems when incorporated into coordinated care. Crucially, trials emphasize that clinical benefit depends not on technology but on a prompt clinical response, multidisciplinary cooperation, and ongoing interaction between the patient and the doctor. New technologies-including voice-based biomarkers, smartphone-derived photoplethysmography, ballistocardiography, and artificial intelligence-driven data integration-may help transition RPM from a hardware-based system to a scalable, "deviceless" approach. CONCLUSIONS Digital medicine is a game-changer for reimagining HF care, involving not only continuous monitoring of physiological changes but also personalized, proactive clinical decision-making. To implement truly patient-centered, predictive HF management in the years to come, technological innovation must be combined with human connection, ethical governance, and health-system readiness.
